2BB score and signals
X4 Pharmaceuticals, Inc.’s current 2BB score is 26 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 25 | Low |
| Momentum | 31 | Weakening |
| Financial strength | 21 | Weak |
| Quality | 53 | Normal |
| Risk | 56 | Moderate |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | Mar 13, 2019 |
| Employees | 45 |
| 52-week range | $2.43 – $4.83 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-15 | — | -0.204 | — | $2.33M |
| 2026-11-03 | — | -0.1897 | — | $2.35M |
| 2026-08-06 | — | -0.1836 | — | $2.47M |
| 2026-05-06 | -0.16 | -0.204 | $2.71M | $3.26M |
Related companies
